Antea Group USA Wins Global Innovation Challenge Grand Prize for Groundbreaking Climate Risk Assessment Service
The winning team from Antea Group USA, comprised of Natalya Holm, Audrey Beattie, Celine Morris, Laurell Ahn, and Eileen Lo, developed the Global Climate Risk Assessments service to address the urgent need for public and private companies to quantify and disclose the potential financial impacts of climate-related risks on their organizations. This comprehensive service is designed to align with the Task Force on Climate-related Financial Disclosures (TCFD) framework and emerging global regulations, helping clients navigate both current and future climate states.
'We are incredibly proud of the remarkable achievement of our team in winning the Global Innovation Challenge 2025,' said Brian Ricketts, CEO of Antea Group USA. 'Their approach to Global Climate Risk Assessments exemplifies the forward-thinking mindset and dedication to addressing critical climate-related challenges for our clients. This service not only helps our clients meet complex regulatory demands but also provides them with actionable insights to build resilience and drive sustainable growth. It truly sets a shining example of innovation, teamwork, and excellence.'
The Global Climate Risk Assessments service offers a structured, five-step approach:
'Winning this award is a tremendous honor,' says Natalya Holm. 'We hope this service empowers businesses to confidently move forward in their sustainability journeys, providing them with the clear data and strategic insights needed to understand, manage, and disclose their climate-related financial risks effectively.'
The victory of Global Climate Risk Assessments underscores Antea Group's dedication to leading the industry with innovative solutions that provide tangible value to clients facing evolving environmental and regulatory landscapes. This achievement reinforces the company's position as a forward-thinking partner in sustainability and environmental consulting.
About Antea Group
Antea®Group is an environment, health, safety, and sustainability consulting firm. By combining strategic thinking with technical expertise, we do more than effectively solve client challenges; we deliver sustainable results for a better future. We work in partnership with and advise many of the world's most sustainable companies to address ESG-business challenges in a way that fits their pace and unique objectives. Our consultants equip organizations to better understand threats, capture opportunities and find their position of strength. Lastly, we maintain a global perspective on ESG issues through not only our work with multinational clients, but also through our sister organizations in Europe, Asia, and Latin America and as a founding member of the Inogen Alliance. Learn more at us.anteagroup.com.Contact:Alison BryantMarketing Director [email protected]us.anteagroup.com
Visit 3BL Media to see more multimedia and stories from Antea Group
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
an hour ago
- Business Wire
LICT Corporation Appoints Joe Cecin as Chief Operating Officer
RYE, N.Y.--(BUSINESS WIRE)-- LICT Corporation (OTC Pink®: LICT) ('LICT' or the 'Company) is pleased to announce the appointment of Joe Cecin as LICT's Chief Operating Officer, effective immediately. 'We are privileged to welcome Joe to LICT Corporation as our new Chief Operating Officer," said Mario Gabelli, Interim Chief Executive Officer of LICT. "With significant experience in the telecommunications industry and a track record of leading complex operating initiatives, Joe brings the operational rigor that will help us expand our market position and deliver sustained value to our customers and all our stakeholders. I am confident that his leadership will be instrumental as we continue to grow and execute on our strategic priorities.' Mr. Cecin has more than 30 years of experience in the telecommunications industry. Mr. Cecin holds a Bachelor of Science degree in Electrical Engineering from the United States Military Academy at West Point and a Master of Business Administration from Stanford University. Mr. Cecin served as an officer in the United States Army's 25 th Infantry Division and is a qualified parachutist, rappel master, and earned the U.S. Army Ranger tab. Prior to joining LICT, Mr. Cecin served as Chief Executive Officer of Ontivity, a leading private-equity backed provider of telecommunications infrastructure engineering and construction services to carriers and infrastructure providers nationwide. He was also Chief Executive Officer of The Hylan Group and Executive Vice President – Operations of UniTek Global Services, both private-equity backed providers of communications infrastructure design, engineering and construction services for wireline, wireless and smart city service operators across the United States. Earlier in his career, Mr. Cecin was Chief Operating Officer of RCN Corporation, a competitive cable television and internet services provider and Managing Director of BB&T Capital Markets, the investment banking division of BB&T Corporation (now Truist). About LICT Corporation LICT Corporation is a holding company with subsidiaries in broadband and other telecommunications services that seeks acquisitions, principally in its existing business areas. LICT Corporation is listed on the OTC Pink® under the symbol LICT. For further information visit our website at
Business Upturn
2 hours ago
- Business Upturn
Cidara Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
By GlobeNewswire Published on July 2, 2025, 01:59 IST SAN DIEGO, July 01, 2025 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company applying its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced that the Compensation and Human Capital Committee of its Board of Directors (Compensation Committee) granted non-qualified stock option awards and restricted stock units (RSUs) for an aggregate of 12,100 shares of its common stock to two new employees, pursuant to the Cidara Therapeutics, Inc. 2020 Inducement Incentive Plan, as amended (the Inducement Plan), with a grant date of June 30, 2025. The stock option has an exercise price of $48.71 per share, which is equal to the closing price of Cidara's common stock on the grant date. The shares subject to the option will vest over four years, with 25% of the shares vesting on the one-year anniversary of the vesting commencement date and the balance of the shares vesting in a series of 36 successive equal monthly installments thereafter. All RSUs vest in four equal annual installments, with 1/4 vesting on each of the first, second, third and fourth anniversaries of the Quarterly Vesting Date (as defined below) that occurs during the calendar quarter that includes the date of grant. 'Quarterly Vesting Date' means March 10, June 10, September 10 or December 10. The awards are subject to the award holder's continuous service through each vesting date and to the terms and conditions of the Inducement Plan and the standard forms of grant agreements thereunder. The foregoing equity awards were granted as inducements material to the employees entering into employment with Cidara, in accordance with Nasdaq Listing Rule 5635(c)(4). The Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously employees of Cidara, or following a bona fide period of non-employment, as an inducement material to such individual's entering into employment with Cidara, pursuant to Nasdaq Listing Rule 5635(c)(4). About Cidara Therapeutics Cidara Therapeutics is using its proprietary Cloudbreak® platform to develop novel drug-Fc conjugates (DFCs) comprising targeted small molecules or peptides coupled to a proprietary human antibody fragment (Fc). Cidara's lead DFC candidate, CD388, is a long-acting antiviral designed to achieve universal prevention of seasonal and pandemic influenza with a single dose by directly inhibiting viral proliferation. In June 2023, CD388 was granted Fast Track Designation by the U.S. Food and Drug Administration (FDA), and the Company announced completion of enrollment of its Phase 2b NAVIGATE trial in December 2024. Additional DFCs have been developed for oncology and in July 2024 Cidara received investigational new drug application clearance for CBO421 which is intended to target CD73 in solid tumors. Cidara is headquartered in San Diego, California. For more information, please visit INVESTOR CONTACT: Brian RitchieLifeSci Advisors(212) 915-2578 [email protected] MEDIA CONTACT: Michael FitzhughLifeSci Communications(628) 234-3889 Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
Business Wire
4 hours ago
- Business Wire
Valmont Industries, Inc. Announces Timing of Second Quarter 2025 Earnings Release and Conference Call
OMAHA, Neb--(BUSINESS WIRE)--Valmont ® Industries, Inc. (NYSE: VMI), a global leader that provides products and solutions to support vital infrastructure and advance agricultural productivity, will release its second quarter 2025 financial results before the market opens on Tuesday, July 22, 2025. Following the earnings release, Avner M. Applbaum, President and Chief Executive Officer, and Thomas Liguori, Executive Vice President and Chief Financial Officer, will host a webcast and conference call at 8:00 a.m. CT on Tuesday, July 22, 2025 to discuss the financial results. To participate in the live call, you may dial +1 877.407.6184 or +1 201.389.0877 (no Conference ID needed), or connect via webcast using this link: Valmont Industries 2Q 2025 Earnings Conference Call. A slide presentation will simultaneously be available for download on the Investors page of A replay of the event can be accessed three hours after the call at the above link or by telephone at +1 877.660.6853 or +1 201.612.7415. Please use access code 13750347. The replay will be available through 10:59 p.m. CT on July 29, 2025. About Valmont Industries, Inc. For nearly 80 years, Valmont has been a global leader that provides products and solutions to support vital infrastructure and advance agricultural productivity. We are committed to customer-focused innovation that delivers lasting value. Learn more about how we're Conserving Resources. Improving Life. ® at
